Clinical Trial Update: A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 3 trial evaluating neoadjuvant TS-1 in combination with cisplatin for Type 4 and large Type 3 gastr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• TS-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Haruhiko Fukuda | Conditions: Gastric Neoplasm | Phase 3 | Status: COMPLETED